Senti Biosciences Holdings (SNTI) Current Taxes (2021 - 2022)

Senti Biosciences Holdings (SNTI) posted quarterly Current Taxes of $50044.0 for Q1 2022, down 69.46% quarter-over-quarter from $163839.0 in Q4 2021.

Senti Biosciences Holdings (SNTI) Current Taxes (2021 - 2022) Analysis & Trends

Senti Biosciences Holdings' Current Taxes history runs 2 years deep, the most recent figure standing at $50044.0 for Q1 2022.

In Q1 2022, Current Taxes changed N/A year-over-year to $50044.0; the TTM figure through Mar 2022 stood at $50044.0 (changed N/A YoY), while the FY2021 annual figure was $163839.0, changed N/A from the prior year.
Current Taxes for Q1 2022 stood at $50044.0, down from $163839.0 in the prior quarter.
The five-year high for Current Taxes was $163839.0 in Q4 2021, with the low at $50044.0 in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	138.65 Bn	130.80 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.93 Bn	77.94 Bn	3.93 Bn	-
3	Argenx Se	64.84 Bn	59.66 Bn	1.37 Bn	49.00 Mn
4	Moderna	57.38 Bn	52.25 Bn	52.00 Mn	-
5	BeOne Medicines	41.94 Bn	36.84 Bn	1.53 Bn	76.32 Mn
6	Alnylam Pharmaceuticals	31.54 Bn	28.23 Bn	992.69 Mn	-
7	BioNTech SE	27.72 Bn	9.33 Bn	668.28 Mn	76.36 Mn
8	Insmed	27.49 Bn	26.33 Bn	358.27 Mn	-
9	Royalty Pharma	27.33 Bn	26.49 Bn	-	-
10	Senti Biosciences Holdings	11.93 Mn	11.93 Mn	-	-

Download Data